Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer

Clinical trial NCT01961544 · COMPLETED

Trial details

NCT number: NCT01961544
Sponsor: Eisai Korea Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Neoplasms Breast Cancer

Start date: 2013-06-01
Primary completion: 2015-07-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.